Fastest to patients
AxelaRx Biosciences Inc. is our San Diego based accelerator. AxelaRx applies molecular imaging techniques to accelerate the drug development of its programs. These programs consist of licensed intellectual property for small and large molecules in therapies in oncology, immunotherapy and inflammation.
AxelaRx offers an up to 50% faster time to market than the conventional method offered by other accelerators. This results from providing business expertise and partnering with TRACER as its in-house CRO for molecular optical imaging services.
AxelaRx offers management, business development, regulatory and all other necessary capabilities provided by industry veterans and world leading scientists in the field. This ensures a successful fastest time-to-market and high return to its shareholders.